Antitumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma
View/ Open
Author
Suzuki, Rikio
Hidehsima, Teru
Mimura, Naoya
Minami, Jiro
Kikuchi, Shohei
Utsugi, Teruhiro
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1038/leu.2014.300Metadata
Show full item recordCitation
Suzuki, R., T. Hidehsima, N. Mimura, J. Minami, H. Ohguchi, S. Kikuchi, Y. Yoshida, et al. 2014. “Antitumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma.” Leukemia 29 (2): 510-514. doi:10.1038/leu.2014.300. http://dx.doi.org/10.1038/leu.2014.300.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318711/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:21462192
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)